Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
16.19
-0.07 (-0.43%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Erasca Market Cap
Erasca has a market cap or net worth of $5.66 billion as of September 4, 2026. Its market cap has increased by 1,295.95% in one year.
Market Cap
5.66B
Enterprise Value
5.32B
1-Year Change
1,295.95%
Ranking
Category
Stock Price
$16.19
ChartMarket Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has increased from $1.86B to $5.66B, an increase of 204.72%. That is a compound annual growth rate of 24.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 5.66B | 436.54% |
| Dec 31, 2025 | 1.06B | 48.72% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mirum Pharmaceuticals | 6.55B |
| Travere Therapeutics | 6.15B |
| Oruka Therapeutics | 6.13B |
| Dianthus Therapeutics | 6.05B |
| Cogent Biosciences | 6.03B |
| Xenon Pharmaceuticals | 5.79B |
| PTC Therapeutics | 5.78B |
| Ligand Pharmaceuticals | 5.69B |